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Abstract
Background:  Renal artery stenosis (RAS) is a known cause of hypertension and ischemic
nephropathy. Stenting of the artery is a valid approach, in spite of cases of unexpected adverse
evolution of renal function.
Methods: In this study, 27 patients with unilateral RAS were subjected to stenting and followed
for a period of one year, while 19 patients were observed while on medical treatment only. The
group of 27 patients, 67.33 ± 6.8 years of age, creatinine of 2.15 ± 0.9 mg/dl, following stenting,
were followed at intervals with biochemical tests, renal scintigraphy and doppler ultrasonography.
The control group (70.0 ± 6.1 years, creatinine 1.99 ± 0.7 mg/dl) was also followed for one year.
Result: One year after stenting mean creatinine clearance (Ccr) increased from 36.07 ± 17.2 to
40.4 ± 21.6 ml/min (NS). Arterial BP, decreased after 1,3,6, and 12 months (p < 0.05). The number
of antihypertensive drugs also decreased (p < 0.05). A significant increase in proteinuria was also
observed. In the control group both Ccr, BP and proteinuria did not show significant changes.
Based on renal scintigraphy and Ccr at subsequent times, it was possibile to evaluate the
timecourse of renal function in both kidneys of the stented patients. In the stented kidneys Ccr
increased significantly. On the controlateral kidney a decrease of renal function (p < 0.05) was
observed. Resistance index appeared to be a risk factor of the functional outcome.
Conclusions: Stenting of RAS due to atherosclerosis is followed by stabilization or improvement
of Ccr, mainly at the stented kidney, while contralateral renal function showed a decrease.
Background
Renal artery stenosis due to atherosclerotic changes of the
renal arteries has become a serious concern as a cause of
hypertension and renal ischemia, resulting frequently in
end-stage renal failure [1,2]. Several epidemiologic stud-
ies have shown the elevated prevalence of ischemic
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nephropathy, with special regard to atherosclerotic renal
artery stenosis, in elderly patients [3,4]. Instead of the clas-
sical surgical approach, percutaneous balloon angioplasty
or endovascular stenting have recently become accepted
procedures in the attempt to revascularize the stenotic
kidney and prevent chronic renal insufficiency. However,
in spite of the arterial dilatation obtained with these pro-
cedures, there is still some doubt that the long-term out-
come is in general satisfactory [5]. There is currently no
clear evidence that such interventions prevent further pro-
gressive decline of renal function. However the results
have been somewhat different in different case series
[6,7]. It is known that there are patients with satisfactory
results in terms of improvement or stabilization of renal
function, while some cases may deteriorate renal function
in spite of the dilating procedure [8,9]. As for the results
of stenotic artery dilatation procedure on blood pressure,
most of reports have confirmed a significant fall in systolic
and diastolic blood pressure [10,11], an important find-
ing which however cannot justify the stenting procedure if
not accompanied by a consensual improvement in kidney
perfusion and stabilization or improvement of renal func-
tion. Therefore the purpose of many researchers has been
to identify the risk factors which might exclude patients
from the revascularizing procedure, due to predictable
poor outcome. Radermacher et al. [12] have identified the
resistance index (RI) as an important factor predicting the
outcome of the stenting. In addition, a limited number of
studies [9,13,14] have evaluated not only the overall renal
glomerular filtration following the dilating procedure, but
also the individual function of the stented and contralat-
eral kidneys. The results are interesting since the behav-
iour of the two kidneys after the one-sided dilating
procedure was found to be divergent. This study provides
further data on the evaluation of the two kidneys with a
follow-up of one year.
Methods
The study has been carried out prospectively on 46
patients affected by hemodynamically significant athero-
sclerotic renal artery stenosis, detected by Magnetic Reso-
nance Angiography or Selective Digital Angiography. All
the patients had a unilateral stenosis. 27 patients (diabe-
tes mellitus in 8 cases) were subjected to stenting of the
stenotic renal artery while 19 patients (diabetes mellitus
in 9 cases) were kept on medical treatment only. Clinical
data of the two groups are reported in table 1. Patients
were allotted to the control group in case of refusal of the
invasive procedure. All patients had a stenosis judged by
ultrasonography to be above 70%.
Table 1: Clinical and biochemical data of the stented and control groups
Stented Control
Patient, n° 27 19
age, years 67,3 ± 6,8 70.0 ± 6,1 n.s
M/F, n° 17/10 15/4 n.s.
Systolic BP, mmHg 169,1 ± 23 165,8 ± 24,7 n.s.
Diastolic BP, mmHg 89,1 ± 14,8 87,4 ± 13,4 n.s.
Creatinine, mg/dl 2,15 ± 0,9 1,99 ± 0,7 n.s.
Cr. Clearance, ml/min 36,1 ± 17,3 34,6 ± 15,6 n.s.
Urea, mg/dl 73,2 ± 36,7 75,5 ± 29,2 n.s.
Tot. Cholesterol, mg/dl 236,9 ± 33,8 241,1 ± 41,2 n.s.
Tryglicerides, mg/dl 181,2 ± 87,6 166,1 ± 82,8 n.s.
Sodium, mEq/L 139,7 ± 5,2 142,0 ± 3,3 n.s.
Potassium, mEq/L 4,34 ± 0,5 4,7 ± 0,6 n.s.
Proteinuria, mg/24 h 308 ± 323 545 ± 572 n.s.
Uric acid, mg/dl 6,8 ± 1,4 6,6 ± 2,3 n.s.
Resistance Index (DDS) 0,76± 0,11 (25) 0,79± 0,04 n.s.
Severity of stenosis (%) 78,8 ± 8,66 (25) 79,06 ± 9,0 n.s.
%%
Smoker 14/27 51,9 12/19 63,2 n.s.
Hypertension 25/27 92,6 19/19 100 n.s.
Diabetes Mellitus 8/27 29,6 9/19 47,4 n.s.
Dyslipidemia 17/27 63 15/19 78,9 n.s.
Peripheral arterial insuff. 17/27 63 13/19 76,5 n.s.BMC Nephrology 2004, 5:15 http://www.biomedcentral.com/1471-2369/5/15
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In all these patients the renal artery was approached
through the femoral artery. French 6 guiding catheter
(type "Cobra"or "Bates") was used for selective renal
artery angiography and for positioning the stent. All sten-
otic lesions were repaired with stainless stent Express Vas-
cular SD Monorail 5.5-6-15/20 mm.premounted on a
balloon catheter on Choice extra support 014" guide. In
these cases primary stenting was performed. The proce-
dure requires, usually, an injection containing 30 ml of
50–50 mixture of isotonic contrast and normal saline.
The patients were followed at the outpatient clinic of the
Nephrology unit. Duplex-doppler sonography and renal
scintigraphy were carried out basally and following 1,3,6
and 12 months after the stenting procedure. At the same
times, biochemical parameters, like serum creatinine and
proteinuria were measured. Creatinine clearance was eval-
uated with the Cockcroft and Gault formula [15].
Doppler ultrasonography was carried out after fasting, fol-
lowing a three days of a low fibre diet and without smok-
ing for a minimum of six hours before the procedure.
Patients were studied with an Acuson 120 XP/4 (Acuson
Corp., Mountain View, CA), equipped with a 3.5 MHz
transducer, with longitudinal anterior, lateral and oblique
approach, with at least threefold sampling of parameters
along the artery. The standard criteria for the diagnosis of
significant renal artery stenosis have been previously
reported [4].
Renal radionuclide scintigraphy was performed with a
gamma camera (Starcam 4000, General Electric, USA)
with 99mTc-DTPA or with 99mTc-MAG3 (mercap-
toacetyltriglycine). MAG3 was chosen in patients with cre-
atinine clearance <25 ml/min. Diuretics and/or ACE
inhibitors were discontinued at least three days before, if
treatment was underway. The criteria of positivity have
previously been reported [4].
Evaluation of single kidney renal creatinine clearance was
performed by measurement of creatinine clearance and
simultaneous renal scintigraphy with MAG3, with per-
centage-wise function of each kidney, enabling to calcu-
late the creatinine clearance pertaining to each kidney.
The entire set of data for this evaluation was available in
21/27 patients.
Statistical analysis. A descriptive univariate analysis, con-
sisting in evaluation of percentages, means and standard
deviations has been carried out as first step. To evaluate
the dependence among the nominal variables, a Parson's
Chi square test was also carried out. In case of not appli-
cable Chi square test due to low theoretical frequencies
(<5), Fischer exact test for tables 2 × 2 was employed.
Comparison of means of the two groups was made. Since
the data did not show a normal distribution, non para-
metric tests, as Wilcoxon rank-sum test for paired data and
Mann-Whitney test, were employed. The significance level
was <0.05, as usual. The more interesting significant and
not significant data were represented graphically. The data
were evaluated with the statistical package BMDP Release
7 (Cork, Ireland,1997).
Results
Clinical and biochemical data of the treated and control
groups are reported in Table 1. There was no significant
difference between experimental and control groups.
During 12 months observation period one patient of the
stented group began dialysis treatment, while in the con-
trol group 4 patients died of cardiovascular events and
one patient started the dialysis treatment.
A significant drop in systolic and diastolic blood pressure
at all control times compared to basal values, was found
in the stented patients, while no significant blood pres-
sure drop was found in the patients not undergoing the
PTA stenting procedure (Table 2). A significant fall in
number of antihypertensive drugs was also found at 3 and
6 months after the stenting.
A significant increase in proteinuria following the stenting
was found at 1 and at 12 months, while the increment in
proteinuria observed at the other control times was only
borderline significant. There was no diference in the
increase of proteinuria between patients with and without
diabetes mellitus. No changes in proteinuria was observed
in the control group.
An increase in creatinine clearance and a slight fall in
serum creatinine, however not reaching a significance
level, was observed in the stented group, while no incre-
ment in creatinine clearance was found in the control
group (Table 3). This observation is however limited by
the fall in the number of the control group due to death
and beginning of dialysis in a total of 5 patients. However
the analysis of the separate renal function in the stented
and non stented kidneys of the experimental group
showed differences in behaviour at the two sides. An
increment in the percentage of total glomerular filtration
in the stented kidney as a group was found, while a signif-
icant fall in percentage of filtration was found on the con-
trolateral side (Fig. 1).
In addition, patients with the stent were divided in those
cases with a RI above 0.80 and cases with this parameter
below 0.80. The patients with lower RI improved, on aver-
age, renal function while the patients with elevated RI had
a worse outcome (Fig. 2). RI values correlated negativelyBMC Nephrology 2004, 5:15 http://www.biomedcentral.com/1471-2369/5/15
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with changes in creatinine clearance from baselines (r = -
0.6712, p < 0.01)(Fig. 3).
Discussion
The advantage deriving from positioning a stent in a sig-
nificantly stenotic renal artery has been debated in recent
years. Generally favorable results have been reported by
Dorros et al [10] on a wide cohort of patients, with special
regard to patients with preserved renal function. Leder-
man et al [8] have found either improvement or
stabilization of renal function in 73 % of 300 patients
with atherosclerotic renal artery stenosis, bilateral in 48%
of cases. Beutler et al. [16] have found similar results on
patients with atherosclerotic ostial renal artery stenosis.
Perkovi et al [17] consider, as risk factors for an unfavora-
ble outcome, diabetes mellitus, advanced age and renal
failure, while the use of ACE inhibitors following the
stenting procedure was protective toward death or deteri-
oration of renal failure. Airoldi et al [9] have given a mes-
sage of caution in extending the dilating procedure to all
the patients with renal artery stenosis, due to the low rate
of renal improvements and of fall in blood pressure, in
their experience, with the finding of at least 20% of
restenosis. On the contrary, renal function improvement
or stabilization was found in 94% of cases by Rocha-Sing
et al. [18], in patients who had a progressive decline of
renal function prior to stent implantation.
In our experience, the fall in blood pressure and of the
number of antihypertensive drugs was confirmed. Our
results on the overall outcome of renal function, over a
one year observation period, in patients with one sided
renal artery stenosis of atherosclerotic origin, have been
satisfactory. As a risk factor of worse outcome, our data
Table 2: Timecourse of blood pressure (mm Hg), number of antihypertensive drugs and proteinuria (mg/24 h) in the stented and control 
groups
STENTED GROUP
Systolic BP Diastolic BP n° antihypertensive 
drugs
Proteinuria
Basal 169 ± 23 89 ± 14,8 2,07 ± 1,1 309 ± 323
1 m 155 ± 12,9* 81,9 ± 6,77* 1,93 ± 1,07 764 ± 690*
3 m 157 ± 17,7* 82,0 ± 6,31* 1,6 ± 1,05* 1381 ± 2160
6 m 148 ± 12,2* 81,4 ± 5,39* 1,42 ± 0,93* 1743 ± 2884
12 m 152 ± 14,4* 81,2 ± 8,87* 1,7 ± 1,17 1377 ± 1643*
CONTROL GROUP
Systolic BP Diastolic BP n° antihypertensive 
drugs
Proteinuria
Basal 165,8 ± 24,6 87,4 ± 13,4 2,37 ± 0,83 545 ± 572
3 m 163,7 ± 16,5 83,0 ± 10,2 2,26 ± 0,93 534 ± 404
6 m 155,6 ± 20,4 88,1 ± 8,45 1,82 ± 0,73 812 ± 536
12 m 154,4 ± 20,8 87,1 ± 8,21 2,0 ± 0,94 225 ± 368
(*) = Significant difference compared to basal value (p < 0,05)
Table 3: Evolution of creatinine clearance (ml/min) and serum creatinine (mg/dl).
STENTED GROUP CONTROL ROUP
Global Ccr Serum Cr Global Ccr Serum Cr
Basal 36,07 ± 17,2 (27) 2,15 ± 0,94 34,78 ± 15,5 (19) 1,99 ± 0,72
1 m 35,29 ± 16,39 2,32 ± 1,33 - -
3 m 34,78 ± 14,38 2,18 ± 0,76 29,99 ± 12,4 2,13 ± 0,73
6 m 37,03 ± 18,0 2,15 ± 0,94 33,84 ± 17,9 2,01± 0,66
12 m 40,42 ± 21,63 (26) 2,03 ± 0,73 34,78 ± 14,3 (14) 1,98 ± 0,56BMC Nephrology 2004, 5:15 http://www.biomedcentral.com/1471-2369/5/15
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have confirmed that RI above 0.80, results in a less satis-
factory outcome compared to patients with RI lower than
0.80, as already reported by Radermacher et al. [12]. The
stenting procedure, in our experience, was not followed
by restenosis or other ischemic complications. Stabiliza-
tion of renal function observed in the control group
should take into account the unfavorable outcome of 5
cases, four deaths and one starting dialysis during the
observation period. Anyhow a rational selection of
patients who might get benefit from the procedure is
advocated. The differences in the percentage of complica-
tions following the stenting procedure, as reported in the
literature [19], might suggest at least in part the possibility
of differences in the individual surgeon's skill in position-
ing the stent.
As for the increment in proteinuria observed following
stenting of renal artery, this finding has not been reported
previously, while in basal conditions significant proteinu-
ria in patients with renal artery stenosis has been already
reported in the literature [20]. Therefore proteinuria does
not exclude the diagnosis of renal ischemia as a cause of
renal failure. Proteinuria is probably connected with the
type of renal lesions due to chronic ischemia, like focal
and segmental glomerulosclerosis, or ischemic glomeru-
lar damage. Glomerular lesions resembling focal glomer-
ulosclerosis have been reported in patients with renal
artery stenosis [21]. The increase in proteinuria following
stenting should probably be attributed to increased per-
fusion pressure in damaged sclerotic glomeruli.
Evolution of percent GFR in the stented and controlateral kidneys Figure 1
Evolution of percent GFR in the stented and controlateral kidneys.
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Less is known of the renal function in the kidney affected
by the arterial stenosis, following the stenting procedure,
compared to the contralateral kidney. In all our patients
renal artery stenosis was of atherosclerotic origin, without
cases of fibromuscular dysplasia. In general, no adverse
events were found following the stenting in the patients
closely followed for one year. In our experience, there
were no apparent cases of cholesterol embolization, of
thrombosis of the artery, of occlusion of the stent, or of
dissecation of the renal artery. The function of the stented
kidney improved in most of patients while a reduction of
renal function was observed in the controlateral kidney.
The overall renal function was stable. Similar findings
have been published by Airoldi et al., Leertouwer et al.,
and La Batide-Alanore et al. [9,13,14]. However their
patient cohorts were rather different. One third of the
cases of Airoldi et al. [9] were affected by fibromuscular
hyperplasia. In only seven of the 27 patients a Palmaz
stent was inserted. The increment in glomerular filtration
rate of the stenotic kidney was more evident in the cases
with fibromuscular dysplasia. Also in the Leertouwer et al.
experience [14], renal artery dilatation was carried out in
atherosclerotic renal artery stenosis, while the average age
of the patients was younger than in our experimental
group. Dilatation of the artery was able to induce an
improvement of glomerular filtration rate of the treated
kidney, although the overall glomerular filtration rate did
not change. In La Batide et al. experience [13], 14/32
patients had renal artery stenosis due to fibromuscular
hyperplasia and also the average age was decisively
Timecourse of creatinine clearance in stented patients with Resistance index < and > of 0.80 Figure 2
Timecourse of creatinine clearance in stented patients with Resistance index < and > of 0.80. Significance of the difference is 
indicated (*)
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younger than our experimental group. Therefore, in our
cases, with selective atherosclerotic renal artery disease
and an older age, an improvement in function of the
stenotic kidney following the stenting procedure was also
observed and deserves to be underlined.
The reduction in contralateral kidney function has been
attributed to ultrafiltration in the non stenotic kidney,
declining after stenting of the stenotic contralateral renal
artery. In addition, hemodynamic factors consequent to a
decrease in renin-angiotensin activity could be considered
as a factor. The involvement of the renin angiotensin
system in renal artery stenosis should be suspected due to
the significant fall in systolic and diastolic blood pressure
following the procedure, an occurrence not found in the
control group. Actually, a fall in plasma renin activity or
concentration following dilatation of the stenotic artery
has been reported by Airoldi et al [9] and by Leertouwer et
al. [14].
Conclusions
In conclusion, the stenting procedure of a stenotic renal
artery does not seem to carry important risks, and is
accompanied by a definite improvement of the stented
kidney, with some reduction of the filtration rate of the
controlateral kidney. This event cannot be considered
unfavorable, since it denounces a condition of hyperfiltra-
tion of the kidney, probably, if left unchanged, able to
induce a deterioration of renal function with time. There-
fore, also in case of overall stabilization of renal function
following the stenting procedure, improvement of the
stented side and reduction of hyperfiltration on the con-
tralateral side are both favorable evolutions for long-term
success of the revascularization procedure. The results are
Inverse correlation between Resistance index and changes in creatinine clearance after stenting Figure 3
Inverse correlation between Resistance index and changes in creatinine clearance after stenting
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less satisfactory in patients with RI >0.80. They should
probably be excluded from the stenting procedure.
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